Recursion Pharmaceuticals, Inc. (RXRX) SEC Filings — 2025
15 SEC filings for Recursion Pharmaceuticals, Inc. (RXRX) in 2025.
Filings
- Recursion Pharmaceuticals, Inc. 8-K Filing — 8-K · Dec 8, 2025
- Recursion Pharmaceuticals Files 8-K — 8-K · Nov 26, 2025
- Recursion's Losses Widen Amid Soaring R&D Spend — 10-Q · Nov 5, 2025
- Recursion Pharmaceuticals Files 8-K — 8-K · Oct 29, 2025
- Recursion Pharmaceuticals Files 8-K/A Amendment — 8-K/A · Aug 29, 2025
- Recursion Pharma's Revenue Soars, But Net Losses Widen to $105.3M — 10-Q · Aug 5, 2025
- Recursion Pharmaceuticals Files 8-K on Equity Sales — 8-K · Jul 8, 2025
- Recursion Pharmaceuticals Files 8-K on Shareholder Votes — 8-K · Jun 18, 2025
- Recursion Pharmaceuticals, Inc. 8-K Filing — 8-K · Jun 10, 2025
- Recursion Pharmaceuticals Files 8-K — 8-K · May 9, 2025
- Recursion Pharma Q1 Revenue Dips Amid R&D Focus — 10-Q · May 5, 2025
- Recursion Pharmaceuticals, Inc. DEF 14A Filing — DEF 14A · Apr 28, 2025
- Recursion Pharma Names New CMO, Chief Medical Officer Departs — 8-K · Mar 18, 2025
- Recursion Pharmaceuticals, Inc. 10-K Filing — 10-K · Feb 28, 2025
- Recursion Pharmaceuticals Files 8-K — 8-K · Jan 13, 2025